Ariel Hanson

Associate Director, Program Management at Rubius Therapeutics - Cambridge, Massachusetts, US

Ariel Hanson's Colleagues at Rubius Therapeutics
Matthew Sanborn

Senior Benefits & HR Operations Specialist

Contact Matthew Sanborn

Hillary Adams

Associate Clinical Trial Manager

Contact Hillary Adams

Tony Fontes

Senior Manager, Maintenance and Metrology

Contact Tony Fontes

Denise Call

Quality Assurance Senior Documentation Specialist

Contact Denise Call

Jason Vieira

Senior Manager Quality Operations

Contact Jason Vieira

Bryan Chin

Clinical Trial Manager

Contact Bryan Chin

View All Ariel Hanson's Colleagues
Ariel Hanson's Contact Details
HQ
(617) 679-9600
Location
Company
Rubius Therapeutics
Ariel Hanson's Company Details

Rubius Therapeutics

Cambridge, Massachusetts, US • 250 - 499 Employees
BioTech/Drugs

Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.

Rubius Therapeutics Rubius Red Platform Rubius Rubius Therapeutics Pitch Deck Rubius Thera
Details about Rubius Therapeutics
Frequently Asked Questions about Ariel Hanson
Ariel Hanson currently works for Rubius Therapeutics.
Ariel Hanson's role at Rubius Therapeutics is Associate Director, Program Management.
Ariel Hanson's email address is ***@rubiustx.com. To view Ariel Hanson's full email address, please signup to ConnectPlex.
Ariel Hanson works in the BioTech/Drugs industry.
Ariel Hanson's colleagues at Rubius Therapeutics are Matthew Sanborn, Hillary Adams, Tony Fontes, Yvonne Eaton, Denise Call, Jason Vieira, Bryan Chin and others.
Ariel Hanson's phone number is (617) 679-9600
See more information about Ariel Hanson